Laura Magnano Selected Research

Laura Magnano Research Topics

Disease

15	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 01/2017
8	Neoplasms (Cancer) 10/2023 - 04/2017
4	Lymphoma (Lymphomas) 01/2023 - 01/2018
3	Monoclonal Gammopathy of Undetermined Significance 04/2021 - 01/2015
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 05/2015
2	Infections 01/2024 - 10/2023
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 12/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 04/2019
2	Multiple Myeloma 12/2018 - 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	COVID-19 01/2024
1	Septic Shock (Toxic Shock Syndrome) 01/2024
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023
1	Bacterial Infections (Bacterial Infection) 10/2023
1	Cross Infection (Nosocomial Infection) 10/2023
1	Lysinuric Protein Intolerance 10/2023
1	Cytopenia 01/2022
1	Lymphadenopathy 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2021
1	Paraproteinemias (Monoclonal Gammopathy) 04/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2019
1	Trisomy (Trisomies) 01/2019
1	Disease Progression 01/2019
1	Immunoglobulin Light-chain Amyloidosis 06/2018
1	Smoldering Multiple Myeloma 01/2018
1	Second Primary Neoplasms (Neoplasms, Second) 10/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2017
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2014

Drug/Important Bio-Agent (IBA)

7	Rituximab (Mabthera)FDA Link 01/2020 - 05/2015
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 01/2019
3	Chimeric Antigen ReceptorsIBA 10/2023 - 04/2019
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 12/2017
2	Immunoglobulin M (IgM)IBA 04/2021 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2017
1	nirmatrelvir and ritonavir drug combinationIBA 01/2024
1	remdesivirIBA 01/2024
1	Antiviral Agents (Antivirals)IBA 01/2024
1	Oxygen (Dioxygen)IBA 01/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023
1	Amino Acids FDA Link 10/2023
1	Serum AlbuminIBA 01/2022
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2022
1	Hexachlorobenzene (HCB)IBA 01/2022
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	CytokinesIBA 01/2020
1	idelalisibIBA 01/2020
1	venetoclaxIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	ibrutinibIBA 04/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	SuspensionsIBA 01/2019
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2018
1	ParaffinIBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2017
1	fludarabineIBA 04/2017
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Thrombopoietin ReceptorsIBA 09/2014

Therapy/Procedure

7	Therapeutics 10/2023 - 04/2017
7	Stem Cell Transplantation 12/2019 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2023 - 05/2015
2	Immunotherapy 01/2020 - 12/2019
2	Secondary Prevention 12/2019 - 12/2018
1	Catheters 10/2023
1	Salvage Therapy 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Hematopoietic Stem Cell Transplantation 12/2018
1	Induction Chemotherapy 01/2018